Skip to content

Pilot Study of ONO-1101 in Patients Scheduled for Multi-slice CT

Pilot Study of ONO-1101 in Patients Scheduled for Multi-slice Computed Tomography (CT) Due to Suspected Coronary Artery Disease

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00311038
Enrollment
90
Registered
2006-04-05
Start date
2006-04-30
Completion date
Unknown
Last updated
2012-06-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Artery Disease

Keywords

ONO-1101, Landiolol Hydrochloride, Multi-slice CT, Coronary Artery Disease

Brief summary

The purpose of this study is to evaluate the efficacy and safety of ONO-1101 in patients scheduled for multi-slice CT.

Interventions

Sponsors

Ono Pharmaceutical Co. Ltd
Lead SponsorINDUSTRY

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
20 Years to 74 Years
Healthy volunteers
No

Inclusion criteria

1. 20-74 years old 2. Heart rate less than 90 beats/min more than 70 beats/min at entering the CT room

Exclusion criteria

1. Previous allergic reactions to contrast agent 2. Renal failure 3. Asthma 4. Other

Design outcomes

Primary

MeasureTime frame
safety
heart rate
image quality

Countries

Japan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026